More on VRTX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $501.95 |
|
|||
| Open | $501.95 | ||||
| 52 Wk High | $134.71 | ||||
| 52 Wk Low | $73.31 | ||||
| Day High | $501.95 | ||||
| Day Low | $501.95 | ||||
| P/E | N/A | ||||
| EPS | $-1.98 | ||||
| Volume | 731 | ||||
- Form 4 VERTEX PHARMACEUTICALS For: Oct 15 Filed by: SACHS BRUCE I
- Form 4 VERTEX PHARMACEUTICALS For: Oct 15 Filed by: Garber Alan M
- Vortex Energy Corp. Announces Extension of Marketing Program
- Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
- Vertex (VRTX) PT Lowered to $667 at BofA Securities
- Vertex reports Alyftrek may reverse pancreatic insufficiency in young CF patients
- Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
- Raymond James sees strong demand for APOL1-mediated FSGS therapies
- Vertex (VRTX) PT Raised to $576 at RBC Capital
- Vertex to Announce Third Quarter 2026 Financial Results November 2nd
Entities mentioned with VRTX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
